Corbus Pharmaceuticals (CRBP) Earnings Date, Estimates & Call Transcripts $7.57 -0.19 (-2.45%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Corbus Pharmaceuticals Earnings Summary Corbus Pharmaceuticals issued Q1 2025 earnings on May 6, 2025, reporting an EPS of -$1.39, which missed the consensus estimate of -$1.26 by $0.13. With a trailing EPS of -$4.22, Corbus Pharmaceuticals' earnings are expected to decrease next year, from ($4.23) to ($6.29) per share. Upcoming Q2 Earnings DateAug. 5Before Market OpensEstimatedConsensus EPS (May. 6) -$1.26 Actual EPS (May. 6) -$1.39 Missed By -$0.13 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)CRBP Upcoming EarningsCorbus Pharmaceuticals' next earnings date is estimated for Tuesday, August 5, 2025, based on past reporting schedules. Powered by Get Corbus Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Corbus Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCRBP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Corbus Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$2.74-$0.92-$1.55Q2 20255-$3.00-$0.89-$1.62Q3 20255-$3.28-$0.96-$1.71Q4 20255-$3.59-$0.90-$1.75 FY 2025 18 -$12.61 -$3.67 -$6.62 Q1 20261-$1.02-$1.02-$1.02Q2 20261-$1.01-$1.01-$1.01Q3 20261-$1.08-$1.08-$1.08Q4 20261-$1.07-$1.07-$1.07 Corbus Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/5/2025(Estimated)--------5/6/2025Q1 2025-$1.26-$1.39 -$0.13-$1.39--3/11/2025Q4 2024-$1.02-$0.78+$0.24-$0.78--11/7/2024--$0.99-$1.15 -$0.16-$1.15--8/6/2024Q2 2024-$1.19-$0.90+$0.29-$0.90--5/7/2024Q1 2024-$1.09-$0.83+$0.26-$0.83--3/12/2024Q4 2023-$2.36-$1.81+$0.55-$1.81--11/7/2023Q3 2023-$2.06-$2.27 -$0.21-$2.27--8/8/2023Q2 2023-$3.10-$2.05+$1.05-$2.05-- Corbus Pharmaceuticals Earnings - Frequently Asked Questions When is Corbus Pharmaceuticals's earnings date? Corbus Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on CRBP's earnings history. Did Corbus Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Corbus Pharmaceuticals (NASDAQ:CRBP) missed the analysts' consensus estimate of ($1.26) by $0.13 with a reported earnings per share (EPS) of ($1.39). Learn more on analysts' earnings estimate vs. CRBP's actual earnings. How much profit does Corbus Pharmaceuticals generate each year? Corbus Pharmaceuticals (NASDAQ:CRBP) has a recorded net income of -$44.60 million. CRBP has generated -$4.22 earnings per share over the last four quarters. What is Corbus Pharmaceuticals's EPS forecast for next year? Corbus Pharmaceuticals's earnings are expected to decrease from ($4.23) per share to ($6.29) per share in the next year. More Earnings Resources from MarketBeat Related Companies SANA Earnings FULC Earnings RAPP Earnings ATAI Earnings URGN Earnings ORIC Earnings MREO Earnings BNTC Earnings TKNO Earnings CKPT Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:CRBP) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corbus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corbus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
